000 01351 a2200385 4500
005 20250513054405.0
264 0 _c19940719
008 199407s 0 0 eng d
022 _a0024-3205
024 7 _a10.1016/0024-3205(94)00879-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGordon, I
245 0 0 _a[3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.
_h[electronic resource]
260 _bLife sciences
_c1994
300 _a189-99 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntidepressive Agents
_xpharmacology
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aCell Membrane
_xdrug effects
650 0 4 _aCorpus Striatum
_xmetabolism
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLigands
650 0 4 _aMale
650 0 4 _aMazindol
_xpharmacology
650 0 4 _aNeurotransmitter Uptake Inhibitors
_xpharmacology
650 0 4 _aPiperazines
_xmetabolism
650 0 4 _aRats
700 1 _aWeizman, R
700 1 _aRehavi, M
773 0 _tLife sciences
_gvol. 55
_gno. 3
_gp. 189-99
856 4 0 _uhttps://doi.org/10.1016/0024-3205(94)00879-5
_zAvailable from publisher's website
999 _c8007089
_d8007089